These results suggest that combining IMRT with MWD may enhance therapeutic efficacy by more effectively downregulating tumor markers and the levels of TGF-β, bEGF, and HMGA1, improving tumor control, and enhancing the QoL of patients. This evidence concerns the gene HMGA1 and neoplasm.